ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2236

Articular Inflammation Is Protected By Fat-1 During The Acute Phase Of Arthritis In Mice

Sang-Il Lee1, Yun-Hong Cheon2, Ji-Min Kim3 and Won Seok Lee2, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 2Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Animal models, inflammatory arthritis, osteoclasts, rheumatoid arthritis (RA) and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Omega-3 polyunsaturated fatty acids (n-3 PUFA) are well known to exert anti-inflammatory effects. The Fat-1 transgenic (Fat-1 TG) mice are capable of producing n-3 PUFA from the n-6 type and are emerging as a new tool for studying the role of n-3 PUFA without the interference of the potential confounding factors of diet. Therefore, this study was carried out to evaluate whether Fat-1 over-expression attenuate arthritis severity in passive K/BxN murine arthritis.

Methods: K/BxN serum transfer arthritis was induced in Fat-1 TG and age-matched wild type (WT) mice. Arthritis severity was assessed by clinical and histopathologic scoring. The levels of inflammatory cytokines in the joints and serum were measured by quantitative PCR and ELISA. The effect of Fat-1 on osteoclastogenesis was assessed using bone marrow monocytes (BMMs) and cytokine expression was assessed using fibroblast-like synoviocytes (FLS) from Fat-1 TG or WT mice.

Results: In the K/BxN serum transfer model, Fat-1 TG mice had significantly less severe arthritis than WT until day 6. The clinical scores were: 3.3 ± 0.5 in Fat-1 TG and 5.7 ± 0.3 in WT; p < 0.01) and the ankle diameter were: 2.17 ± 0.03 mm in Fat-1 TG and 2.35 ± 0.03 mm in WT; p < 0.01). The ankle joints from Fat-1 TG mice showed significantly decreased inflammation and bone erosion than WT (scores = 0.75 ± 0.2 and 2.21 ± 0.4, for Fat-1 TG and WT, respectively; p < 0.05). These effects were paralleled by decreased levels of IL-1β, IL-6, MCP-1, and MMP-3. The BMMs of Fat-1 TG mice resulted in reduced osteoclastogenesis than WT. TNF-α stimulated FLS of Fat-1 TG mice displayed lower NF-kB activity than WT, resulting in decreased transcriptional activation of proinflammatory target genes.

Conclusion: These results suggest that Fat-1 plays a critical regulatory role in the NF-kB pathway and the expression of target genes and controls articular inflammation during the acute phase of K/BxN serum transfer-induced arthritis.


Disclosure:

S. I. Lee,
None;

Y. H. Cheon,
None;

J. M. Kim,
None;

W. S. Lee,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/articular-inflammation-is-protected-by-fat-1-during-the-acute-phase-of-arthritis-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology